Model parameter | Values | Foundations/assumptions | Reference |
---|---|---|---|
Dynamic variables | Â | Â | Â |
x1: c(cAMP) | 4 μM | Basal levels | [14] |
x2:c(cGMP) | 0.4 μM | Basal levels | [14] |
x3:c(PDE2) active | 0.05 mg/l | Model-based simulation | This study |
 |  | Experimentally: 63.46 mg/l |  |
x4:c(PDE3) active | 2.3 mg/l | Model-based simulation | This study |
 |  | Experimentally: 225 mg/l |  |
x5:c(PDE5) active | 1 mg/l | Model-based simulation | This study |
 |  | Experimentally: 1359 mg/l |  |
x6:c(PDE2) inactive | (63.46 -x3) mg/l | Â | Â |
x7:c(PDE3) inactive | (225 - x4) mg/l | Â | Â |
x8:c(PDE5) inactive | (1359 - x5) mg/l | Â | Â |
x9:c(AMP) | μM; simulated |  |  |
x10:c(GMP) | μM; simulated |  |  |
Constants | Â | Â | Â |
k1: Vmax PDE2 | 120 μmol/min/mg | cAMP turnover | |
k2:Km PDE2 | 50 μM | cAMP turnover | |
k3:Vmax PDE3 | 3 μmol/min/mg | cAMP turnover | |
k4:Km PDE3 | 0.2 μM | cAMP turnover | |
k5:Vmax PDE2 | 120 μmol/min/mg | cGMP turnover | |
k6:Km PDE2 | 35 μM | cGMP turnover | |
k7:Vmax PDE3 | 0.3 μmol/min/mg | cGMP turnover | |
k8:Km PDE3 | 0.02 μM | cGMP turnover | |
k9:Vmax PDE5 | 5 μmol/min/mg | cGMP turnover | |
k10:Km PDE5 | 5 μM | cGMP turnover | |
k11:kcAMP | 8 μmol/min | Basal influx of cAMP | |
k12:kcGMP | 1 μmol/min | Basal influx of cGMP | |
k13:Deactivation PDE2 | Â | Â | This study |
k14:Activation PDE2 | k13-k18: = 0 | Â | This study |
k15:Deactivation PDE3 | for simulation of | Â | This study |
k16:Activation PDE3 | basal levels | Â | This study |
k17:Deactivation PDE5 | (resting conditions) | Â | This study |
k18:Activation PDE5 | Â | Â | This study |
k19:hPDE2 | 2 | Hill coefficient |